纤维蛋白原联合尿微量蛋白检测在冠心病诊断中的应用价值  

Application value of urinary microprotein and fibrinogen in the diagnosis of coronary heart disease

作　　者：安新宇 An Xinyu(Department of Clinical Laboratory,Tianjin Hongqiao Hospital of Traditional Chinese Medicine,Tianjin 300132,China)

机构地区：[1]天津市红桥区中医医院,天津300132

出　　处：《首都食品与医药》2023年第3期98-100,共3页Capital Food Medicine

摘　　要：目的探讨纤维蛋白原联合尿微量蛋白检测在冠心病诊断中的应用价值.方法选取天津市红桥区中医医院2021年1月-2021年12月接诊的72例冠心病患者作为观察组,选取同期健康体检者72例作为对照组,两组均检测尿微量蛋白与纤维蛋白原水平,对比两组的检测结果.结果观察组的尿微量蛋白与血清纤维蛋白原水平均明显高于对照组,其中以急性心肌梗死组的血清纤维蛋白原和尿微量蛋白水平最高(P<0.05).结论纤维蛋白原联合尿微量蛋白检测在冠心病诊断中有着较高的价值,为冠心病的临床诊断提供有效依据.Objective To investigate the application value of urinary microprotein and fibrinogen in the diagnosis of coronary heart disease.Methods A total of 72 patients with coronary heart disease admitted to our hospital from January 2021 to December 2021 were accepted as observation group,and 72 healthy people were accepted as control group in corresponding period.The levels of urinary microprotein and fibrinogen were detected in both groups,and the detection results of the two groups were compared.Results The levels of urinary microprotein and serum fibrinogen in observation group were significantly higher than those in control group,and the levels of urinary microprotein and serum fibrinogen in patients with acute myocardial infarction were the highest(P<0.05).Conclusion The detection of microprotein and fibrinogen in urine has high clinical diagnostic value in the diagnosis of coronary heart disease,and provides an effective reference for the clinical diagnosis of coronary heart disease.

关 键 词：冠心病 纤维蛋白原 尿微量蛋白 诊断价值 

分 类 号：R541.4[医药卫生—心血管疾病]